Health

STAT+: Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 13/11/2026, 09:36:24 UTC.

Briefings

Eli Lilly's telehealth provider Counsel Health is expected to be acquired by Oura, a smart ring maker, creating a conflict of interest for the pharmaceutical giant. Counsel clinicians will gain access to Oura's health data to assist patients with GLP-1 prescriptions. This acquisition complicates existing relationships between major pharma firms and telehealth providers.

Key points

• Eli Lilly's telehealth provider Counsel Health is expected to be acquired by Oura, a smart ring maker.
• Counsel clinicians will gain access to Oura's health data to assist patients with GLP-1 prescriptions.

Context

Pharma companies promoting telehealth providers for GLP-1 prescriptions have increased. Oura's acquisition of Counsel Health complicates these relationships as clinicians now have access to Oura's data.

Limitations

The acquisition timeline is not specified. The source does not confirm whether Counsel Health is a direct competitor or if the acquisition will impact existing partnerships.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 13/11/2026, 09:40:15 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidarnoorqkufuhg4kpblxp6ga523lglkk5om2h6melnx7vk5zhvue